Last $35.63 USD
Change Today -0.07 / -0.20%
Volume 30.1K
USPH On Other Exchanges
Symbol
Exchange
Berlin
New York
As of 8:04 PM 09/2/14 All times are local (Market data is delayed by at least 15 minutes).

u.s. physical therapy inc (USPH) Key Developments

US Physical Therapy Inc. Elects Mr. Edward L. Kuntz as Board of Director

US Physical Therapy Inc. announced that Mr. Edward L. Kuntz has been elected to the Company's Board of Directors expanding the size of the Board to 11 members. Mr. Kuntz is the former Chairman and Chief Executive Officer of Kindred Healthcare. He also serves as a director of Rotech Healthcare and American Electric Technologies Inc.

Us Physical Therapy Inc. Declares Quarterly Dividend, Payable on September 5, 2014

US Physical Therapy Inc. announced that its board of directors declared a quarterly dividend of $0.12 per share to holders of record of common stock as of the close of business on August 18, 2014 payable on September 5, 2014.

US Physical Therapy Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014; Revises Earnings Guidance for the Year 2014

US Physical Therapy Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company’s net revenues increased 16.9% from $66.9 million to $78.2 million in the second quarter of 2014, due to an increase in patient visits of 17.1% from 0.614 million to 0.719 million and a slight increase in the average net revenue per visit to $106.39 from $106.25. Operating income from continuing operations was $14.2 million against $11.1 million last year. Income before taxes from continuing operations was $13.9 million against $10.9 million last year. Net income from continuing operations including non-controlling interests was $9.4 million against $7.6 million last year. Net income including non-controlling interests was $9.4 million against $7.4 million last year. Net income attributable to common shareholders was $6.4 million as compared to $4.9 million in the second quarter of 2013. Basic and diluted earnings per share were $0.53 compared to $0.41 in the comparable 2013 period. Basic and diluted earnings per share from continuing operations rose to $0.53 as compared to $0.42 in the comparable 2013 period. Adjusted EBITDA from operations including noncontrolling interests was $16.518 million against $13.159 million a year ago. Adjusted EBITDA was $13.530 million against $10.606 million a year ago. For the six months, the company’s net revenues increased 14.2% from $129.6 million to $148.0 million, due to an increase in patient visits of 14.4% from 1.191 million to 1.363 million. Operating income from continuing operations was $23.7 million against $19.5 million last year. Income before taxes from continuing operations was $23.2 million against $19.2 million last year. Net income from continuing operations including non-controlling interests was $15.7 million against $13.5 million last year. Net income including non-controlling interests was $15.7 million against $13 million last year. Net income attributable to common shareholders was $10.7 million compared to $8.6 million for the six months ended June 30, 2013. Diluted earnings per share were $0.87 against $0.72 per basic and diluted share last year. Diluted earnings per share from continuing operations rose to $0.87 as compared to $0.74 per basic and diluted share in the comparable 2013 period. Net cash provided by operating activities was $21.1 million against $20.7 million last year. Purchase of fixed assets was $2.1 million against $2.4 million last year. Adjusted EBITDA from operations including noncontrolling interests was $28.154 million against $23.585 million a year ago. Adjusted EBITDA was $23.071 million against $19.074 million a year ago. The company is revising and raising earnings guidance from continuing operations for the year 2014 to be in the range of $20.0 million to $20.9 million in net income and $1.64 to $1.70 in diluted earnings per share. Earlier guidance issued in March was for annual net income in the range of $18.8 million to $19.6 million and $1.53 to $1.60 in diluted earnings per share. The guidance range represents projected earnings from existing operations only and excludes future potential acquisitions.

US Physical Therapy Inc. to Report Q2, 2014 Results on Aug 07, 2014

US Physical Therapy Inc. announced that they will report Q2, 2014 results at 9:00 AM, Eastern Standard Time on Aug 07, 2014

US Physical Therapy Inc., Q2 2014 Earnings Call, Aug 07, 2014

US Physical Therapy Inc., Q2 2014 Earnings Call, Aug 07, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
USPH:US $35.63 USD -0.07

USPH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Select Medical Holdings Corp $13.98 USD -0.04
View Industry Companies
 

Industry Analysis

USPH

Industry Average

Valuation USPH Industry Range
Price/Earnings 23.8x
Price/Sales 1.6x
Price/Book 3.2x
Price/Cash Flow 29.6x
TEV/Sales 1.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact U.S. PHYSICAL THERAPY INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.